ABVC News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

AB

Volume

28.04K

Next Earnings

October 30th

Loading chart

AB

ABVCABVC BioPharma, Inc. Common Stock

ABVC

Pay with—

Available Balance0.00

AB

Mkt Cap

$24.5M

Volume

28.04K

Next Earnings

October 30th

Chart Financials Earnings News About Insider Filings

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per ShareFREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that the Company's subsidiary AiBtl BioPharma Inc. acquired TT Life Company, an established player in the precision medicine industry. The acquisition includes Malaysian Import Trading Company, Direct Sales Company, and Taiwanese Direct Sales Company, which are estimated to be approximately equivalent to $8.33M. AiBtl purchased 100% shares of TT Life by swapping its 1.66M shares at $5 per share. This strategic move positions AiBtl to expand its portfolio further and accelerate innovation in the rapidly growing precision medicine market while consolidating the financials, including the revenue, profit, and cash flow, with TT Life.GlobeNewswire Inc. · Apr 18, 2024

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60MFREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that each of the Company and its subsidiary BioFirst Corporation entered into a global licensing agreement with ForSeeCon Eye Corporation (FEYE) for the Company's Ophthalmology pipeline, which includes the medical device Vitargus® (valued at $187M, by third-party valuer) (the "Licensed Products"). This license will cover the Licensed Products' clinical trial, registration, manufacturing, supply, and distribution rights.GlobeNewswire Inc. · Mar 26, 2024

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business UpdateFREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes, announced its 2023 annual financial and operating results. These results, including the financial statements included herein, can be found in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2024.GlobeNewswire Inc. · Mar 14, 2024

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per ShareFREMONT, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agreement to acquire real estate in Taoyuan City, Taiwan. The acquisition of real estate assets, estimated at approximately $2.96 million via an equity transfer of $3.50 per share, is to develop plant factories for ABVC’s botanical pipeline strategically; ABVC hopes the property will ultimately be used as an integrated platform for the global development of the Asian healthcare business and the medical, pharmaceutical, and biotechnology industries.GlobeNewswire Inc. · Feb 8, 2024

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance. For the fourth quarter, the company expects revenue of $634 million-$638 million (vs. $636.39 million) and adjusted operating income of $241 million-$247 million. The company's previous implied guidance was $623 million-$648 million in revenue. Wolfe Research analyst Shreyas Patil downgraded Mobileye Global from Outperform to Peer Perform. Mobileye Global shares dipped 23.5% to $30.37 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim, Inc. (NASDAQ: MINM) shares jumped 170.2% to $4.62. Omega Therapeutics, Inc. (NASDAQ: OMGA) gained 92.7% to $5.26 after Novo Nordisk entered into a research collaboration with the company. Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 65.8% to $0.2920 after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol. Jeffs' Brands Ltd(NASDAQ: JFBR) gained 40% to $4.41 after surging 25% on Wednesday. Jeffs' Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology. Mobix Labs, Inc. (NASDAQ: MOBX) gained 33.3% to $4.00. Mobix Labs was awarded 15-month contract to supply EMI filtered connectors as part of US Army's M-1 Abrams Tank Program. ATIF Holdings Limited (NASDAQ: ATIF) jumped 30.6% to $1.32. Adicet Bio, Inc. (NASDAQ: ACET) surged 26.1% to $2.22. Adicet Bio issued corporate updates and highlighted upcoming priorities for its pipeline programs in 2024. Smart for Life, Inc. (NASDAQ:Benzinga · Jan 4, 2024

Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving PremarketShares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter. Resources Connection posted quarterly adjusted earnings of 28 cents per share, beating market estimates of 18 cents per share. The company’s quarterly sales came in at $163.1 million versus expectations of $161.936 million. Resources Connection shares jumped 6.5% to $14.58 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Jeffs' Brands Ltd(NASDAQ: JFBR) gained 60.6% to $5.06 in pre-market trading after surging 25% on Wednesday. Jeffs' Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology. Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 41% to $0.1984 in pre-market trading after falling over 11% on Wednesday. Kintara Therapeutics, last month, announced a review of strategic alternatives focused on maximizing stockholder value. The Arena Group Holdings, Inc. (NYSE: AREN) shares rose 26.8% to $2.65 in pre-market trading after falling over 9% on Wednesday. Arena Group Board, last month, terminated employment of CEO Ross Levinsohn. 180 Life Sciences Corp. (NASDAQ: ATNF) shares gained 24.4% to $0.2550 in pre-market ...Benzinga · Jan 4, 2024

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock. Keefe, Bruyette & Woods analyst Michael Perito downgraded SoFi from a Market Perform rating to an Underperform rating and lowered the price target from $7.50 to $6.50, citing recent outperformance and a change in the analyst's model. SoFi Technologies shares dipped 12.8% to $8.41 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers NexImmune, Inc. (NASDAQ: NEXI) shares rose 150.8% to $6.14 after gaining over 6% on Tuesday. Trinity Place Holdings Inc. (NYSE: TPHS) rose gained 62.6% to $0.1857. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Sigma Additive Solutions, Inc.(NASDAQ: SASI) gained 60.3% to $4.65. Sigma Additive Solutions, announced in an 8-K Filing, the approval of the issuance of the shares of common stock in exchange for all the capital stock of NextTrip Holdings. ABVC BioPharma, Inc. (NASDAQ: ABVC) jumped 58.3% to $1.90. ABVC BioPharma and its subsidiary received $460 million from AiBtl BioPharma as the first milestone payment of global licensing fees. Sidus Space, Inc. (NASDAQ: SIDU) rose 48.4% to $10.35. Sidus Space secured NOAA approval to provide imaging services to government and commercial customers. Brera Holdings PLC (NASDAQ: BREA) shares gained 32.8% to $0.97. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 31.2% to $5.01. Roth MKM raised price target on the stock to $40. Elicio Therapeutics, Inc. (NASDAQ: ELTX) gained 29% to $7.65. TDCX Inc. (NYSE: TDCX) gained 28% to $6.18 after it disclosed receiving a preliminary non-binding ...Benzinga · Jan 3, 2024

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing FeesFREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and its subsidiary received an aggregate of 46 million shares from AiBtl BioPharma Inc. ("AiBtl"), as its first milestone payment under a global licensing agreement. The agreement between the Company and AiBtl placed a value of $460 ($10 per share) on such payment. AiBtl is a private company, and the share value is based on the terms of the agreement between the parties and the valuation report done by an independent third party.GlobeNewswire Inc. · Jan 3, 2024

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical StudyFREMONT, CA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced an update on the Company's eight-week long ADHD Phase II part II clinical study taking place at the University of California San Francisco (UCSF) Medical Center and five Taiwanese medical centers. A total of 94 subjects were screened, out of which 69 enrolled in the study; 60 subjects completed the eight-week study.GlobeNewswire Inc. · Dec 7, 2023

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48. For FY23, AEO revised guidance for revenue to be up mid-single digits Y/Y from growth in low single digits Y/Y earlier. American Eagle fell 16.4% to $16.52 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Safe and Green Development Corporation (NASDAQ: SGD) shares gained 66% to $4.7119. Safe and Green Development unveiled a Letter of Intent for integration of real estate AI software. Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) shares jumped 52.4% to $9.92 after falling more than 12% on Monday. Anghami Inc. (NASDAQ: ANGH) shares jumped 36% to $2.1488. OSN Group announced up to $50 million cash investment in Anghami. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares gained 27.9% to $0.2219. TRACON Pharmaceuticals recently announced license of product development platform for $3 million upfront payment. Marpai, Inc. (NASDAQ: MRAI) rose 24.2% to $1.1301. Marpai Form 4 filing showed Eitan Yaron bought 100,000 shares at an average price of $1.23 per share. Symbotic Inc. (NASDAQ: SYM) jumped 23.8% to $46.02 after the company reported better-than-expected fourth-quarter sales results. Burlington Stores, Inc. (NYSE: BURL) gained 19% to $162.77 after the company reported third-quarter financial results and issued guidance. Hibbett, Inc. (NASDAQ: HIBB) jumped 14.7% to $61.55 following strong quarterly sales. LQR House Inc. (NASDAQ: LQR) shares surged 14.5% to $0.0691. LQR House repurchased 1,476,355 shares in its ongoing share ...Benzinga · Nov 21, 2023

to start trading

AB

ABVCABVC BioPharma, Inc. Common Stock

ABVC

Pay with—

Available Balance0.00

Your PositionYou don't own any ABVC yet.

Related Tickers

Earnings